Skip to main content

US ClosedU.S. Closed

NTLA: Intellia Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Intellia Therapeutics, Inc. is a biotechnology firm dedicated to advancing therapeutic treatments through its expertise in genome editing.

52W Range

24thpctl

Volume

0.59×avg

Market Cap

1.80BUSD

P/E Ratio

-3.8TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Intellia Therapeutics, Inc.

NTLANASDAQ Global Market·USD·Closed

Intellia Therapeutics, Inc.

NTLANASDAQ·USD·Closed

$12.87

−1.83%

$12.87

−$0.24 (1.83%)

52W Range

24thpctl

Volume

0.59×avg

Mkt Cap

1.80BUSD

P/E

-3.8TTM

Div Yield

–ann